A NEW PROSPECT FOR WEIGHT CONTROL ?

Experts are excitedly examining retatrutide, a promising drug created by Eli Lilly, as a possible step in physique reduction . Unlike many earlier approaches, retatrutide is a twin-action agonist targeting both GLP-1 and GIP, hormones that impact hunger and blood sugar balance. Initial patient s